Radiotherapy and Immunotherapy: The Power of the Teamwork for the Treatment of NSCLC
Sign Up to like & getrecommendations! Published in 2022 at "AntiCancer Research"
DOI: 10.21873/anticanres.15704
Abstract: Immune checkpoint inhibitors (ICPi) targeting programmed cell death 1(PD-1)/programmed cell death ligand-1 (PD-L1) have revolutionized the treatment of patients with advanced non-small cell lung cancer (NSCLC). Despite impressive success, only a small proportion of patients… read more here.
Keywords: immunotherapy; power teamwork; immunotherapy power; radiotherapy immunotherapy ... See more keywords